title: Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
authors.affiliation: Department of Neurology, University Hospital Hamburg, Hamburg, Germany. F.Leypoldt@uke.uni-hamburg.de
authors.forename: F
authors.initials: F
authors.lastname: Leypoldt
authors.forename: A
authors.initials: A
authors.lastname: Münchau
authors.forename: F
authors.initials: F
authors.lastname: Moeller
authors.forename: M
authors.initials: M
authors.lastname: Bester
authors.forename: C
authors.initials: C
authors.lastname: Gerloff
authors.forename: C
authors.initials: C
authors.lastname: Heesen
mesh_terms: D000328:Adult; D001921:Brain / Q000473:pathology; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000473:pathology; D003287:Contrast Media; D004660:Encephalitis / Q000139:chemically induced* / Q000473:pathology; D017029:Epilepsy, Complex Partial / Q000139:chemically induced / Q000503:physiopathology; D005260:Female; D000068876:Fingolimod Hydrochloride; D005682:Gadolinium; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications / Q000188:drug therapy; D009336:Necrosis; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D003287:Contrast Media; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D005682:Gadolinium; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine